Assessment of mitochondrial toxicity in human cells treated with tenofovir: Comparison with other nucleoside reverse transcriptase inhibitors

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 3, 2002, Pages 716-723

  Birkus, Gabriel ^a   Hitchcock, Michael J M ^a   Cihlar, Tomas ^a  

^a GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; CYTOCHROME C OXIDASE; DIDANOSINE; LACTIC ACID; LAMIVUDINE; MITOCHONDRIAL DNA; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CONTROLLED STUDY; DNA CONTENT; HEPATOBLASTOMA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; IN VITRO STUDY; KIDNEY TUBULE EPITHELIUM; MITOCHONDRION; MUSCLE CELL; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TOXICITY;

ADENINE; CELLS, CULTURED; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX IV; HUMANS; IMMUNOBLOTTING; KIDNEY TUBULES, PROXIMAL; LACTIC ACID; LIVER; MITOCHONDRIA; MUSCLE, SKELETAL; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; REVERSE TRANSCRIPTASE INHIBITORS; TUMOR CELLS, CULTURED;

EID: 0036174438     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.3.716-723.2002     Document Type: Article

References (46)

1. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity
2. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy
3. Phase I/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults
4. Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells
5. Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy
6. Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway
7. 0) yield insight into physiological mechanisms
8. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity
9. Kinetic interaction of the diphosphates of 9-(2-phosphonylmethoxyethyl)adenine and other anti-HIV active purine congeners with HIV reverse transcriptase and human DNA polymerases alpha, beta, and gamma
10. Tenofovir exhibits low cytotoxicity in various human cell types: Comparison with other nucleoside reverse transcriptase inhibitors
11. Incorporation of selected nucleoside phosphonates and anti-human immunodeficiency virus nucleotide analogs into DNA by human DNA polymerase alpha, beta, and gamma
12. Human renal organic anion transporter 1 (h0AT1) and its role in the nephrotoxicity of antiviral nucleotide analogs
13. Cytochrome c oxidase: Structure, function, and membrane topology of the polypeptide subunits
14. Effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells
15. Effect of beta-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells. Implications for predicting drug hepatotoxicity
16. Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells
17. Mitochondrial myopathy caused by long-term zidovudine therapy
18. Zidovudine (AZT) causes an oxidation of mitochondrial DNA in mouse liver
19. AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins
20. Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2′,3′-dideoxycytidine (ddC)
21. Abacavir: A review of its clinical potential in patients with HIV infection
22. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity
23. Mitochondrial toxicity of antiviral drugs
24. Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria
25. Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts
26. Mammalian DNA polymerases alpha, beta, gamma, delta, and epsilon incorporate fialuridine (FIAU) monophosphate into DNA and are inhibited competitively by FIAU triphosphate
27. Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts
28. Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis
29. 0 human fibroblasts: A comparison of subunit proteins in normal fibroblasts treated with ethidium bromide and fibroblasts from a patient with mtDNA depletion syndrome
30. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B
31. Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides
32. Lactic acidosis and hepatic steatosis associated with use of stavudine: Report of four cases
33. Transient alterations in cellular permeability in cultured human proximal tubule cells: Implications for transport studies
34. Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity
35. Assembly of cytochrome-c oxidase in cultured human cells
36. Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells
37. Lack of mitochondrial toxicity in CEM cells treated with carbovir
38. Lamivudine. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection
39. Crosstalk between nuclear and mitochondrial genomes
40. A missense mutation of cytochrome oxidase subunit II causes defective assembly and myopathy
41. Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), bis(isopropyloxymethylcarbonyl) PMPA
42. Metabolism, mitochondrial uptake and toxicity of 2′,3′-dideoxycytidine
43. Zidovudineinduced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: Report of two patients and review of the literature
44. Toxicity and efficacy of 2′,3′-dideoxycytidine in clinical trials of pigtailed macaques infected with simian retrovirus type 2
45. Phosphorylation of the anti-hepatitis B nucleoside analog 1-(2′-deoxy-2′-fluoro-1-beta -D-arabinofuranosyl)-5-iodouracil by human cytosolic and mitochondrial thymidine kinase and implications for cytotoxicity
46. Cytochrome c oxidase deficiency in the muscle of patients with zidovudine myopathy is segmental and affects both mitochondrial DNA and nuclear DNA-encoded subunits